Inhibition of Plasmodium falciparum plasmepsins by drugs targeting HIV-1 protease: A way forward for antimalarial drug discovery

Plasmodium species are causative agents of malaria, a disease that is a serious global health concern. FDA-approved HIV-1 protease inhibitors (HIV-1 PIs) have been reported to be effective in reducing the infection by Plasmodium parasites in the population co-infected with both HIV-1 and malaria. Ho...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Vandana Mishra, Anuradha Deshmukh, Ishan Rathore, Satadru Chakraborty, Swati Patankar, Alla Gustchina, Alexander Wlodawer, Rickey Y. Yada, Prasenjit Bhaumik
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-01-01
Serie:	Current Research in Structural Biology
Soggetti:	Plasmepsins Protease Parasite Malaria Hemoglobin Drug design
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2665928X24000059
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!